Improving the efficacy of cancer immunotherapy with modified CAR-T cells

CAR-T cell therapy is a last hope for many patients with blood, bone marrow or lymph gland cancer when other treatments such as chemotherapy are unsuccessful. A limiting factor of this otherwise very effective and safe therapy is that the cells used in the process quickly reach a state of exhaustion.

Leave A Comment

Your email address will not be published. Required fields are marked *